340 related articles for article (PubMed ID: 23953397)
1. Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies.
Cézard C; Rabbind Singh A; Le Gac G; Gourlaouen I; Ferec C; Rochette J
Blood Cells Mol Dis; 2014 Jan; 52(1):27-34. PubMed ID: 23953397
[TBL] [Abstract][Full Text] [Related]
2. An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]+[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1.
Dupradeau FY; Pissard S; Coulhon MP; Cadet E; Foulon K; Fourcade C; Goossens M; Case DA; Rochette J
Hum Mutat; 2008 Jan; 29(1):206. PubMed ID: 18157833
[TBL] [Abstract][Full Text] [Related]
3. The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.
Ka C; Le Gac G; Dupradeau FY; Rochette J; Férec C
Hum Genet; 2005 Sep; 117(5):467-75. PubMed ID: 15965644
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
6. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
Meier P; Schuff-Werner P; Steiner M
Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis in north-eastern Romania.
Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
[TBL] [Abstract][Full Text] [Related]
9. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
10. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect.
Le Gac G; Dupradeau FY; Mura C; Jacolot S; Scotet V; Esnault G; Mercier AY; Rochette J; Férec C
Blood Cells Mol Dis; 2003; 30(3):231-7. PubMed ID: 12737937
[TBL] [Abstract][Full Text] [Related]
12. The functional significance of E277K and V295A HFE mutations.
Silva B; Martins R; Proença D; Fleming R; Faustino P
Br J Haematol; 2012 Aug; 158(3):399-408. PubMed ID: 22624560
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
15. The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.
Wang J; Chen G; Pantopoulos K
Biochem J; 2003 Mar; 370(Pt 3):891-9. PubMed ID: 12464008
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample.
Vizzi E; Loureiro CL; Gerder M; de las Nieves Garcia-Casal M; Rodríguez-Larralde A; Gerace L; Ludert JE; Liprandi F; Pujol FH
Ann Hematol; 2005 Nov; 84(12):802-6. PubMed ID: 15995871
[TBL] [Abstract][Full Text] [Related]
18. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
19. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
[TBL] [Abstract][Full Text] [Related]
20. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
